StockComparison Logo
vs

RNXT vs POAI

Comparison between RenovoRx Inc (RNXT, Company) and Predictive Oncology Inc (POAI, Company).

Both RNXT and POAI are from the Healthcare sector.

5-Year PerformanceRNXT has outperformed POAI, delivering a return of -36.2% compared to -54.7%

RNXT vs POAI - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
RNXT
$38M
POAI
$38M
Max Drawdown
Winner
RNXT
96.25%
POAI
99.97%
Sharpe Ratio
RNXT
-0.19
Winner
POAI
0.42
5Y Beta
RNXT
0.86
POAI
N/A
Industry
RNXT
Biotechnology
POAI
Health Information Services
P/E Ratio
Winner
RNXT
-2.68
POAI
-0.46
Debt to Equity
RNXT
0.00%
POAI
N/A
Free Cash Flow Yield
RNXT
-29.49%
POAI
N/A
P/S Ratio
Winner
RNXT
25.79
POAI
52.26
P/B Ratio
RNXT
3.40
Winner
POAI
-0.49

RNXT vs POAI - Historical Returns

Returns include dividend reinvestment.

1M
RNXT
-3.32%
Winner
POAI
+6.76%
3M
RNXT
+4.43%
Winner
POAI
+298.32%
6M
RNXT
-12.10%
Winner
POAI
+19.50%
1Y
Winner
RNXT
-37.96%
POAI
-52.12%
5Y(CAGR)
Winner
RNXT
-36.17%
POAI
-54.74%
10Y(CAGR)
RNXT
N/A
POAI
-50.42%
Max(CAGR)
Winner
RNXT
-36.17%
POAI
-50.42%

RNXT vs POAI - Annual Returns (2018 - 2026)

Returns include dividend reinvestment.

YearRNXTPOAI
2026+1.03%+0.35%
2025-38.23%-48.19%
2024-34.85%-76.74%
2023-13.58%-48.01%
2022-52.04%-68.98%
2021-33.33%+32.21%
2020N/A-71.04%
2019N/A-59.85%
2018N/A-26.30%

RNXT vs POAI Drawdown Comparison

The maximum drawdown for RNXT was -96.25%, occurring on Nov 17, 2023. This drawdown has not yet recovered.

The maximum drawdown for POAI was -99.97%, occurring on Mar 18, 2026. This drawdown has not yet recovered.

The current RNXT drawdown is -94.73%. The current POAI drawdown is -99.83%.

RankRNXTPOAI
#1-96.25%
Aug 30, 2021 - Nov 17, 2023
-99.97%
Mar 12, 2018 - Mar 18, 2026
#2N/A-21.32%
Jan 31, 2018 - Mar 12, 2018

Correlation

Correlation between RNXT and POAI is 0.84 which considered as a strong positive correlation - the stocks tend to move together.

0.84
-101

Select Stocks to Compare